Advances in treatment of anxiety and depressive disorders
Lyles, W.B.; Simpson, B.
Journal of the Florida Medical Association 77(8): 731-734
1990
ISSN/ISBN: 0015-4148 PMID: 1979345 Document Number: 357600
Document emailed within 1 workday
Related Documents
Chevalier, A.; Bonenfant, S.; Picot, M.C.; Chastang, J.F.; Luce, D. 1996: Occupational factors of anxiety and depressive disorders in the French National Electricity and Gas Company. The Anxiety-Depression Group Journal of Occupational and Environmental Medicine 38(11): 1098-1107Rzheusskaia, G.V.; Listopadov, I.I.; Bobrova, M.V.; Umrudina, A.G. 2009: Cymbalta (duloxetine) in the treatment of anxiety-depressive disorders in patients with discirculatory encephalopathy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(2): 26-30
Riemann, D. 1996: Anxiety disorders. Diagnosis and therapy in family practice. 1: Anxiety reactions--psychiatric disorders and anxiety--anxiety disorders Fortschritte der Medizin 114(33): 457-459
Salzman, C.; Goldenberg, I.; Bruce, S.E.; Keller, M.B. 2001: Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program Journal of Clinical Psychiatry 62(3): 149-152
Chazova, T.E.; Voznesenskaia, T.G.; Golitsyna, T.I. 2007: Anxiety-depressive disorders in patients with type 2 diabetes mellitus complicated with acute coronary syndrome Kardiologiia 47(6): 10-14
El Kissi, Y.; Maarouf Bouraoui, M.; Amamou, B.; Bannour, A.S.; Ben Romdhane, A.; Ben Nasr, S.; Ali, B.éc.B.H. 2014: Prevalence of anxiety and depressive disorders among the nurses of Sousse Farhat Hached hospital: assessment by the Tunisian version of CIdi La Tunisie Medicale 92(1): 18-23
Cardona-Castrillon, G.P.; Isaza, R.; Zapata-Soto, A.P.; Franco, J.G.; Gonzalez-Berrio, C.; Tamayo-Diaz, C.P. 2007: The comorbidity of major depressive disorder, dysthymic disorder and anxiety disorders with migraine Revista de Neurologia 45(5): 272-275
Talarowska, M.; Zboralski, K.; Gałecki, P. 2012: Results of the MMPI-2 test among patients suffer from depressive disorders and organic depressive disorders Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 32(189): 159-162
Akkaya, C. 2006: Difficulties in the diagnosis and treatment of major depressive disorder with comorbid anxiety symptoms Turk Psikiyatri Dergisi 17(2): 139-146
Breulet, M. 1981: Practical and theoretical aspects of the treatment of depressive disorders Revue Medicale de Liege 36(8): 389-396
Enns, M.W.; Swenson, J.R.; McIntyre, R.S.; Swinson, R.P.; Kennedy, S.H. 2001: Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 46 Suppl. 1: 77s-90s
Clervoy, P.; Corcos, M. 2000: Manic-depressive disorders in adolescence. Lithium treatment Presse Medicale 29(3): 167-170
Volz, H.-P. 2008: Diagnosis and treatment of anxiety disorders MMW Fortschritte der Medizin 150(Suppl 2): 64-67
Motak, E. 1987: The DSM IIi classification of anxiety disorders in the light of psychological models of anxiety Psychiatria Polska 21(6): 533-539
Rzewuska, M.; Sobucka, K. 1993: Buspirone in the treatment of Generalized Anxiety Disorders Psychiatria Polska 27(5): 545-561
Garakani, A.; Mathew, S.J.; Charney, D.S. 2006: Neurobiology of anxiety disorders and implications for treatment Mount Sinai Journal of Medicine new York 73(7): 941-949
Nemeroff, C.B. 2003: The role of GABA in the pathophysiology and treatment of anxiety disorders Psychopharmacology Bulletin 37(4): 133-146
Allgulander, C.; Hirschfeld, R.M.A.; Nutt, D.J. 2002: Long-term treatment strategies in anxiety disorders Psychopharmacology Bulletin 36(Suppl 2): 79-92
Pigott, T.A. 1999: Gender differences in the epidemiology and treatment of anxiety disorders Journal of Clinical Psychiatry 60(Suppl 18): 4-15
De Mesmaeker, S.ép.; Zdanowicz, N.; Reynaert, C.; Jacques, D. 2014: Role of benzodiazepines in the treatment of anxiety disorders in 2014 Psychiatria Danubina 26(Suppl 1): 23-26